Altogether, the consistent lower expression of TGFBI in all FA samples as compared to FTC cases, supported with previously observed in vivo upregulation, suggest that TGFBI is a protein that could be involved in the progression from thyroid adenoma to carcinoma and is therefore a novel candidate marker of malignancy in follicular thyroid tumours. Here, TGFBI is linked to carcinoma.